An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
Nature Communications, and Communications Medicine are interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we invite submissions of papers ...
A phase II trial of dostarlimab and niraparib combination therapy in patients with stage III-IV recurrent or refractory penile cancer. Association of baseline and on-treatment ctDNA fraction with ...
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results